Sheets Smith Wealth Management Gilead Sciences, Inc. Transaction History
Sheets Smith Wealth Management
- $789 Million
- Q1 2025
A detailed history of Sheets Smith Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 7,090 shares of GILD stock, worth $780,538. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,090
Previous 7,089
0.01%
Holding current value
$780,538
Previous $654,000
21.41%
% of portfolio
0.1%
Previous 0.08%
Shares
30 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.9 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.55 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.01 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.9 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...